Bevispas indications
Irritable bowel syndrome & allied conditions eg, chronic irritable colon, spastic constipation, mucous colitis and spastic colitis. Symptomatic treatment of abdominal pain, cramps, nonspecific diarrhoea & flatulence. GI spasm secondary to organic diseases eg, diverticulitis, gastritis, duodenitis, oesophagitis, cholecystitis, Crohn's disease, ulcerative colitis, peptic ulcer, gallbladder disease, hiatus hernia, GIT inflammation.
Uses of Bevispas in details
Bevispas is used to treat irritable bowel syndrome (disorder of the intestines that leads to cramps in the abdomen, gas, bloating and changes in bowel habits). It is also used to treat other conditions that involve spasm and pain related to small and large bowel.
Bevispas description
Each capsule contains Mebeverine 200 mg.
Bevispas also contains the following excipients: Capsule Content (Granules): Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose, methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30% and glycerol triacetate. Capsule Shell: Gelatin, titanium dioxide (E171). Printing Ink: Shellac (E904), black iron oxide (E172), propylene glycol, concentrated ammonia solution, potassium hydroxide.
Bevispas dosage
Adults: 1 capsule twice daily (1 in the morning and 1 in the evening).
Special Populations: Elderly, Renal and Hepatic Impairment: No posology studies in elderly, renal and/or hepatically impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatically impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.
Missed Dose: In case of ≥1 doses missed, continue with the next dose as prescribed; the missed doses are not to be taken in addition to the regular dose.
Administration: The capsules should be swallowed with a sufficient amount of water (at least 100 mL of water).
It should not be chewed because the coating is intended to ensure a prolonged release mechanism.
Bevispas interactions
No interaction studies have been performed except with alcohol. In vitro and in vivo studies in animals have demonstrated the absence of any interaction between Bevispas and ethanol.
Incompatibilities: Not applicable.
Bevispas side effects
Although adverse effects appear rare, gastrointestinal disturbances, dizziness, headache, insomnia, anorexia and tachycardia have been reported in patients receiving Bevispas.
Bevispas contraindications
Hypersensitivity to Bevispas or to any of the excipients of Bevispas.
Active ingredient matches for Bevispas:
Mebeverine in South Africa.
Mebeverine hydrochloride in South Africa.
List of Bevispas substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Bevacol (Lebanon) | |
| Boots IBS Relief (United Kingdom) | |
| Boots Pharmacy IBS Relief (United Kingdom) | |
| Boots Pharmacy IBS Relief 135 mg Tablets (United Kingdom) | |
| Caborin (Pakistan) | |
| Chlorhydrate de Mebeverine | |
| Capsule; Oral; Mebeverine Hydrochloride 200 mg | |
| Chlorhydrate de Mébévérine Mylan (France) | |
| Chum (Taiwan) | |
| Chum 135 mg x 60's | |
| Chum 135 mg x 1000's | |
| Colese (Australia, Taiwan) | |
| Tablet; Oral; Mebeverine Hydrochloride 135 mg (Alphapharm) | |
| Colese 135 mg (Alphapharm) | |
| Colo Relax (Egypt) | |
| Colofac (Australia, Austria, Ireland, Malta, New Zealand, South Africa, Thailand, United Kingdom) | |
| Tablet; Oral; Mebeverine Hydrochloride 135 mg (Solvay) | |
| Colofac Retard 200 mg x 30's (Solvay) | |
| Colofac 135 mg x 50's (Solvay) | |
| Colofac 135 mg (Austria) | |
| Colofac IBS (United Kingdom) | |
| Colofac MR (United Kingdom) | |
| Capsule, Modified Release; Oral; Mebeverine Hydrochloride 200 mg | |
| Colofac retard (Austria) | |
| Colofac retard 200 mg (Austria) | |
| Colofac Tablets 135mg (United Kingdom) | |
| Colofac/Colofac Retard (Thailand) | |
| Colofac Retard PR cap 200 mg 30's (Abbott) | |
| Colofac tab 135 mg 50's (Abbott) | |
| Colonil (Taiwan) | |
| Colonil 135 mg (Quesada) | |
| Colopriv (Algeria, France, Tunisia) | |
| Capsule; Oral; Mebeverine Hydrochloride 200 mg (Expanscience) | |
| Colopriv Gé (Tunisia) | |
| Colospa (Croatia (Hrvatska), India) | |
| COLOSPA Capsule/ Tablet / 135mg / 10 units (Solvay Pharma India Pvt Ltd) | $ 0.87 |
| Colospa 135mg TAB / 10 (Solvay Pharma India Pvt Ltd) | $ 0.94 |
| 135 mg x 10's (Solvay Pharma India Pvt Ltd) | $ 0.94 |
| Colospa 135 mg Tablet (Solvay Pharma India Pvt Ltd) | $ 0.10 |
| COLOSPA 135 MG TABLET 1 strip / 10 tablets each (Solvay Pharma India Pvt Ltd) | $ 1.48 |
| COLOSPA RETARD 200 MG TABLET 1 strip / 10 tablets each (Solvay Pharma India Pvt Ltd) | $ 2.11 |
| COLOSPA X TABLET 1 strip / 15 tablets each (Solvay Pharma India Pvt Ltd) | $ 2.29 |
| COLOSPA sugar-coated tab 135 mg x 10's (Solvay Pharma India Pvt Ltd) | $ 1.12 |
| Colospa 135mg Tablet (Solvay Pharma India Pvt Ltd) | $ 0.16 |
| Colospa 200mg Capsule (Solvay Pharma India Pvt Ltd) | $ 0.23 |
| Colospa X Tablet (Solvay Pharma India Pvt Ltd) | $ 0.17 |
| COLOSPA RETARD (Bosnia & Herzegowina, Croatia (Hrvatska), Serbia) | |
| 200 mg x 10's (Solvay Pharma India Pvt Ltd) | $ 1.37 |
| Colospa Retard 20mg CAP / 10 (Solvay Pharma India Pvt Ltd) | $ 1.37 |
| Colospa Retard 200 mg Capsule (Solvay Pharma India Pvt Ltd) | $ 0.14 |
| COLOSPA RETARD cap 200 mg x 10's (Solvay Pharma India Pvt Ltd) | $ 1.59 |
| Colospa Retard 20mg CAP / 10 (Solvay Pharma India Pvt Ltd) | $ 1.37 |
See 263 substitutes for Bevispas | |
References
- PubChem. "mebeverine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Mebeverine". http://www.drugbank.ca/drugs/DB12554 (accessed September 17, 2018).
- MeSH. "Parasympatholytics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Bevispas are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Bevispas. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
10 consumers reported useful
Was the Bevispas drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 8 | 80.0% | |
| Not useful | 2 | 20.0% | |
12 consumers reported price estimates
Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?The below mentioned numbers have been reported by ndrugs.com website users about whether the Bevispas drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
| Users | % | ||
|---|---|---|---|
| Not expensive | 9 | 75.0% | |
| Expensive | 3 | 25.0% | |
28 consumers reported time for results
To what extent do I have to use Bevispas before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 1 day and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Bevispas. To get the time effectiveness of using Bevispas drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 1 day | 9 | 32.1% | |
| 3 days | 4 | 14.3% | |
| 2 days | 4 | 14.3% | |
| 5 days | 3 | 10.7% | |
| > 3 month | 2 | 7.1% | |
| 1 week | 2 | 7.1% | |
| 3 month | 2 | 7.1% | |
| 2 weeks | 1 | 3.6% | |
| 1 month | 1 | 3.6% | |
477 consumers reported age
| Users | % | ||
|---|---|---|---|
| 6-15 | 181 | 37.9% | |
| > 60 | 83 | 17.4% | |
| 46-60 | 67 | 14.0% | |
| 30-45 | 57 | 11.9% | |
| 16-29 | 55 | 11.5% | |
| 1-5 | 31 | 6.5% | |
| < 1 | 3 | 0.6% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
